Galecto Biotech raised €79M in a Series C round in Oct 2018. The company is based in Copenhagen, Denmark. Investors in the round: Bristol Myers-Squibb, HBM Healthcare Investments, M Ventures and 6 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €79M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
